These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 23993)

  • 21. Antibody against the antigen receptor of a plasmacytoma prolongs survival of mice bearing the tumor.
    Beatty PG; Kim BS; Rowley DA; Coppleson LW
    J Immunol; 1976 May; 116(5):1391-6. PubMed ID: 1270800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myeloma-induced immunosuppression: a multistep mechanism.
    Katzmann JA
    J Immunol; 1978 Oct; 121(4):1405-9. PubMed ID: 701801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of immune response to sheep red blood cells on plasmacytoma MOPC 104 E.
    Ghanta VK; Hiramoto NS; Hiramoto RN
    Cancer Res; 1981 Jun; 41(6):2197-9. PubMed ID: 7237419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of plasmacytomas on serum immunoglobulin levels of BALB/c mice.
    Fenton MR; Havas HF
    J Immunol; 1975 Feb; 114(2 pt 2):793-801. PubMed ID: 1089719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of intracisternal A-particles and of RNA molecules in plasmacytoma-associated immunodeficiency.
    Katzmann J; Bhoopalam N; Heller P; Hwang LT; Ostro M; Lavelle D; Giacomoni D
    Cancer Res; 1978 Aug; 38(8):2555-61. PubMed ID: 307429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of antilymphocytic antibody on the humoral immune response in different strains of mice. 3. The response to type 3 pneumococcus polysaccharide.
    Ghaffar A; James K
    Immunology; 1973 Jun; 24(6):1075-85. PubMed ID: 4146227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced antibody production to type III pneumococcal polysaccharide in mice treated with antilymphocyte serum: evidence for cellular regulatory mechanism of IgM antibody response.
    Barth RF; Baker PJ; Stashak PW; Amsbaugh DF
    Transplant Proc; 1971 Mar; 3(1):800-2. PubMed ID: 4398512
    [No Abstract]   [Full Text] [Related]  

  • 28. Tumor-specific immunity induced by somatic hybrids. II. Elicitation of enhanced immunity against the parent plasmacytoma.
    Kim BS
    J Immunol; 1979 Aug; 123(2):739-44. PubMed ID: 88483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the antibody to the C-carbohydrate produced by a transplantable mouse plasmacytoma.
    Cohn M; Notani G; Rice SA
    Immunochemistry; 1969 Jan; 6(1):111-23. PubMed ID: 4180087
    [No Abstract]   [Full Text] [Related]  

  • 30. Regulation of immune responses aginst the syngeneic ADJ-PC-5 plasmacytoma in BALB-c mice. III. Induction of specific T suppressor cells to the BALB/c plasmacytoma ADJ-PC-5 during early stages of tumorigenesis.
    Haubeck HD; Kölsch E
    Immunology; 1982 Nov; 47(3):503-10. PubMed ID: 6215340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of subcutaneously administered 2,6,10,14-tetramethylpentadecane on plasmacytoma growth.
    Platica M; Bojko C; Steiner G; Hollander VP
    Cancer Res; 1980 Jul; 40(7):2229-33. PubMed ID: 6248200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancement of experimental tumors in mice by treatment with concanavalin A.
    Ekstedt RD
    J Natl Cancer Inst; 1979 Oct; 63(4):1065-9. PubMed ID: 480379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of a zinc-deficient diet on the growth of an IgM-secreting plasmacytoma (TEPC-183).
    Fenton MR; Burke JP; Tursi FD; Arena FP
    J Natl Cancer Inst; 1980 Dec; 65(6):1271-2. PubMed ID: 6933272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protection against MOPC-315 plasmacytoma by immunization with C-type particle preparations.
    Kleinman R; Dray S
    Cancer Res; 1978 Jan; 38(1):223-5. PubMed ID: 201375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune suppression in BALB/c mice bearing the plasmacytoma TEPC-183: evidence for normal lymphocyte but defective macrophage function.
    Joshua DE; Brown G; MacLennan IC
    Int J Cancer; 1979 May; 23(5):663-72. PubMed ID: 378867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune responses to pneumococcal polysaccharide antigens: a comparison of the murine model and the response in humans.
    Schiffman G
    Rev Infect Dis; 1981; 3(2):224-32. PubMed ID: 7020042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapy of the murine plasmacytoma MOPC 104E: role of the immune response.
    Lubet RA; Carlson DE
    J Natl Cancer Inst; 1978 Sep; 61(3):897-903. PubMed ID: 278867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maternal-foetal interaction, antibody formation, and metabolic response in mice immunized with pneumococcal polysacharides.
    Lee CJ
    Immunology; 1980 Sep; 41(1):45-54. PubMed ID: 7429553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of immune responses against the syngeneic ADJ-PC-5 plasmacytoma in BALB/c mice. I. Analysis of immune parameters involved.
    Cihak J; Ziegler HW; Kölsch E
    Immunology; 1981 May; 43(1):133-43. PubMed ID: 6265346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Inhibitory effect of human C-reactive protein (CRP) on the antibody response in mice to pneumococcal C-polysaccharide].
    Nakayama S
    Nihon Saikingaku Zasshi; 1984 Sep; 39(5):809-15. PubMed ID: 6520933
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.